EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa

Asmaa Abdul Hak, Hamdallah H Zedan, Hadir A El-Mahallawy, Gharieb S El-Sayyad, Mai M Zafer

BMC Microbiology · 2024

DOI: 10.1186/s12866-024-03358-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, 2024. Verfasst von Asmaa Abdul Hak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Colistin, Copper, Anti-Bacterial Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Atomic Energy Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Addressing microbial resistance urgently calls for alternative treatment options. This study investigates the impact of a bimetallic formulation containing colistin, silver, and copper oxide on a pandrug-resistant, highly virulent Pseudomonas aeruginosa (P. aeruginosa) isolate from a cancer patient at the National Cancer Institute, Cairo University, Egypt.

Methods

Silver nanoparticles (Ag NPs), copper oxide nanoparticles (CuO NPs), and bimetallic silver-copper oxide nanoparticles (Ag-CuO NPs) were synthesized using gamma rays, combined with colistin (Col), and characterized by various analytical methods. The antimicrobial activity of Col-Ag NPs, Col-CuO NPs, and bimetallic Col-Ag-CuO NPs against P. aeruginosa was evaluated using the agar well diffusion method, and their minimum inhibitory concentration (MIC) was determined using broth microdilution. Virulence factors such as pyocyanin production, swarming motility, and biofilm formation were assessed before and after treatment with bimetallic Col-Ag-CuO NPs. The in vivo efficacy was evaluated using the Galleria mellonella model, and antibacterial mechanism were examined through membrane leakage assay.

Results

The optimal synthesis of Ag NPs occurred at a gamma ray dose of 15.0 kGy, with the highest optical density (OD) of 2.4 at 375 nm. Similarly, CuO NPs had an optimal dose of 15.0 kGy, with an OD of 1.5 at 330 nm. Bimetallic Ag-CuO NPs were most potent at 15.0 kGy, yielding an OD of 1.9 at 425 nm. The MIC of colistin was significantly reduced when combined with nanoparticles: 8 µg/mL for colistin alone, 0.046 µg/mL for Col-Ag NPs, and 0.0117 µg/mL for Col-Ag-CuO NPs. Bimetallic Col-Ag-CuO NPs reduced the MIC four-fold compared to Col-Ag NPs. Increasing the sub-inhibitory concentration of bimetallic nanoparticles from 0.29 × 10 -2 to 0.58 × 10 -2 µg/mL reduced P. aeruginosa swarming by 32–64% and twitching motility by 34–97%. At these concentrations, pyocyanin production decreased by 39–58%, and biofilm formation was inhibited by 33–48%. The nanoparticles were non-toxic to Galleria mellonella , showing 100% survival by day 3, similar to the saline-treated group.

Conclusions

The synthesis of bimetallic Ag-CuO NPs conjugated with colistin presents a promising alternative treatment for combating the challenging P. aeruginosa pathogen in hospital settings. Further research is needed to explore and elucidate the mechanisms underlying the inhibitory effects of colistin-bimetallic Ag-CuO NPs on microbial persistence and dissemination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaColistinCopperAnti-Bacterial AgentsMicrobial Sensitivity TestsSilverMetal NanoparticlesBiofilmsAnimalsPseudomonas InfectionsDrug Resistance, Multiple, BacterialHumansMothsVirulence FactorsEgypt

Stichwörter der Autor:innen

Pseudomonas aeruginosaAntimicrobial activityAntimicrobial resistanceBimetallic nanoparticlesVirulence factors

Substanzen

ColistinCopperAnti-Bacterial AgentsSilvercuprous oxidecupric oxideVirulence Factors

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Clinical Pathology, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt. Gharieb.Elsayyad@acu.edu.eg.
  • Department of Microbiology and Immunology, Faculty of Pharmacy, Galala University, New Galala City, Suez, Egypt. Gharieb.Elsayyad@acu.edu.eg.
  • Drug Microbiology Lab, Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt. Gharieb.Elsayyad@acu.edu.eg.

Förderung

  • Egyptian Atomic Energy Authority

Zitieren

APA

Abdul Hak, A., Zedan, H. H., El-Mahallawy, H. A., El-Sayyad, G. S., & Zafer, M. M. (2024). In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa. BMC Microbiology. https://doi.org/10.1186/s12866-024-03358-6

Vancouver

Abdul Hak A, Zedan HH, El-Mahallawy HA, El-Sayyad GS, Zafer MM. In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa. BMC Microbiology. 2024. doi:10.1186/s12866-024-03358-6

BibTeX
@article{AbdulHak2024,
  author = {Abdul Hak, Asmaa and Zedan, Hamdallah H and El-Mahallawy, Hadir A and El-Sayyad, Gharieb S and Zafer, Mai M},
  title = {In Vivo and in Vitro activity of colistin-conjugated bimetallic silver-copper oxide nanoparticles against Pandrug-resistant Pseudomonas aeruginosa},
  journal = {BMC Microbiology},
  year = {2024},
  doi = {10.1186/s12866-024-03358-6}
}
Kostenlos starten →